Perioperative adverse events and functional outcomes following open and robot‐assisted prostatectomy in patients over age 70

Sancı, Adem; Özkaya, Mehmet Fatih; Oğuz, Efe Semetey; Gökçe, Mehmet İlker; Süer, Evren; Gülpınar, Ömer; Baltacı, Sümer; Türkölmez, Kadír

doi:10.1111/ijcp.14754

Cited by 4 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other studies on gynecological surgical strategies, for example, to treat endometrial cancer or reconstructive pelvic surgery, use a cut-off of 70 or 80 years 14 23 24 25 26 27 28 . Whether robotic-assisted surgery (RAS) can be safely carried out in older patients was recently investigated in urology 29 30 and gastric and colorectal surgery 18 31 . There are almost no clinical data available for the wide range of gynecological indications in older and very old female patients.…”

Section: Age and Basic Characteristicsmentioning

confidence: 99%

“…B. beim Endometriumkarzinom oder in der rekonstruktiven Beckenbodenchirurgie setzen den „cut off“ bei 70 oder 80 Jahren 14 23 24 25 26 27 28 . Ob robotisch assistierte Chirurgie (RAS) bei älteren Menschen sicher durchführbar ist wurde kürzlich für die Urologie 29 30 sowie die Magen- und kolorektale Chirurgie untersucht 18 31 . Für das breite Spektrum gynäkologischer Indikationen bei älteren oder hochbetagten Patientinnen liegen kaum klinische Daten vor.…”

Section: Alter Und Basischarakteristikaunclassified

See 1 more Smart Citation

Robotic-assisted Gynecological Surgery in Older Patients – a Comparative Cohort Study of Perioperative Outcomes

Mothes

Kather

Cepraga

et al. 2023

Geburtshilfe Frauenheilkd

View full text Add to dashboard Cite

Study design Because of current demographic developments, a hypothesis was proposed whereby older female patients aged > 65 years can be safely operated using minimally invasive, robotic-assisted surgery, despite having more preoperative comorbidities. A comparative cohort study was designed to compare the age group ≥ 65 years (older age group, OAG) with the age group < 65 years (younger age group, YAG) after robotic-assisted gynecological surgery (RAS) in two German centers. Patients and methods Consecutive RAS procedures performed between 2016 and 2021 at the Women’s University Hospital of Jena and the Robotic Center Eisenach to treat benign or oncological indications were included in the study. The age groups were compared according to their preoperative comorbidities (ASA, Charlson comorbidity index [CCI], cumulative illness rating scale – geriatric version [CIRS-G]) and perioperative parameters such as Clavien-Dindo (CD) classification of surgical complications. Analysis was performed using Welch’s t-test, chi2 test, and Fisher’s exact test. Results A total of 242 datasets were identified, of which 63 (73 ± 5 years) were OAG and 179 were YAG (48 ± 10 years). Patient characteristics and the percentage of benign or oncological indications did not differ between the two age groups. Comorbidity scores and the percentage of obese patients were higher in the OAG group: CCI (2.7 ± 2.0 vs. 1.5 ± 1.3; p < 0.001), CIRS-G (9.7 ± 3.9 vs. 5.4 ± 2.9; p < 0.001), ASA class II/III (91.8% vs. 74.1%; p = 0.004), obesity (54.1% vs. 38.2%; p = 0.030). There was no difference between age groups, even grouped for benign or oncological indications, with regard to perioperative parameters such as duration of surgery (p = 0.088; p = 0.368), length of hospital stay (p = 0.786; p = 0.814), decrease in Hb levels (p = 0.811; p = 0.058), conversion rate (p = 1.000; p = 1.000) and CD complications (p = 0.433; p = 0.745). Conclusion Although preoperative comorbidity was higher in the group of older female patients, no differences were found between age groups with regard to perioperative outcomes following robotic-assisted gynecological surgery. Patient age is not a contraindication for robotic gynecological surgery.

show abstract